AnnouncementsAjanta Pharma to consider dividend on May 05, 2014
100% of moneycontrol users recommend buying Ajanta Pharma.
What's your call on Ajanta Pharma today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2552.85||-0.12||2939.80||1904.15||43,426.24|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Ajanta Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 3,504.35 crore.The company has reported a standalone sales of Rs 292.59 crore and a Net Profit of Rs 62.42 crore for the quarter ended Dec 2013.
The company management includes Rajesh M Agrawal - Joint Managing Director, K H Viswanathan - Additional Director, Mannalal B Agrawal - Chairman, Purushottam B Agrawal - Vice Chairman, Madhusudan B Agrawal - Vice Chairman, Yogesh M Agrawal - Managing Director, Anil Kumar - Director, Chandrakant M Khetan - Director.
It is listed on the BSE with a BSE Code of 532331 and the NSE with an NSE Code of AJANTPHARM.
Its Registered office is at "Ajanta House", Charkop,,Kandivli (West) Mumbai,Maharashtra - 400067.
Their Registrars are Link Intime India Pvt. Ltd.